Medtronic intact porcine bioprosthesis experience to twelve years

Annals of Thoracic Surgery

Volumn 71, Issue 5, 2001, Pages S278-S281

  Jamieson, W R Eric ^a,b,c   Lemieux, Michel D ^a,b,c   Sullivan, John A ^a,b,c   Munro, A Ian ^a,b,c   Métras, Jacques ^a,b,c   Cartier, Paul C ^a,b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTARALDEHYDE;

ADOLESCENT; ADULT; AGED; AORTA VALVE REPLACEMENT; CANADA; CHILD; CONFERENCE PAPER; FEMALE; FOLLOW UP; HEART VALVE BIOPROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY VALVE; STATISTICAL ANALYSIS; SWINE; TRICUSPID VALVE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; BIOPROSTHESIS; CANADA; CAUSE OF DEATH; CHILD; EQUIPMENT FAILURE ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; PULMONARY VALVE; REOPERATION; TRICUSPID VALVE;

EID: 0035021953     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)02548-6     Document Type: Article

References (14)

1. Lemieux MD, Jamieson WRE, Landymore RW, et al. Medtronic Intact porcine bioprosthesis: clinical performance to seven years. Ann Thorac Surg 1995;60:S258-63.
2. Jamieson WRE, Lemieux MD, Sullivan JAP, Munro AI, Métras J, Cartier PC. Medtronic Intact porcine bioprosthesis: 10 years' experience. Ann Thorac Surg 1998;66:S118-21.
3. Pibarot P, Dumesnil JG, Lemieux M, Cartier P, Métras J, Durand LG. Impact of prosthesis-patient mismatch on hemodynamic and symptomatic status, morbidity and mortality after aortic valve replacement with a bioprosthetic heart valve. J Heart Valve Dis 1998;7:211-8.
4. Thomson DJ, Jamieson WRE, Dumesnil JG, et al. Medtronic Mosaic porcine bioprosthesis satisfactory early clinical performance. Ann Thorac Surg 1998;66:S122-5.
5. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62:932-5.
6. Gaynor JJ, Feuer EJ, Tan CC, et al. On the use of cause-specific failure and conditional failure probabilities: examples for clinical oncology. J Am Stat Assn 1993;88:400-9.
7. Grunkemeier GL, Jamieson WRE, Miller DE, Starr A. Actual versus actuarial risk of structural valve deterioration. J Thorac Cardiovasc Surg 1994;108:709-18.
8. Jaffe WM, Barratt-Boyes BG, Sadri A, Gavin JB, Coverdale HA, Neutze JM. Early follow-up of patients with the Medtronic Intact porcine valve: a new cardiac bioprosthesis. J Thorac Cardiovasc Surg 1989;98:181-92.
9. Barratt-Boyes BG, Jaffe WM, Ko PH, Whitlock RM. The zero pressure fixed Medtronic Intact porcine valve: an 8.5 year review. J Heart Valve Dis 1993;2:604-11.
10. Barratt-Boyes BG, Jaffe WM, Whitlock RM. The Medtronic Intact porcine valve: ten-year clinical review. J Thoracic Cardiovasic Surg 1998;116:1005-14.
11. Jamieson WRE, Ling H, Burr LH, et al. Carpentier-Edwards supra-annular porcine bioprosthesis evaluation over 15 years. Ann Thorac Surg 1998;66:S49-52.
12. David TE, Armstrong S, Sun Z. The Hancock II bioprosthesis at ten years. Ann Thorac Surg 1995;60:S229-34.
13. David TE, Armstrong S, Sun Z. The Hancock II bioprosthesis at twelve years. Ann Thorac Surg 1998;66:S95-8.
14. Mykén P, Bech-Hanssen O, Phipps B, Caidahl K. Fifteen years follow-up with the St. Jude Medical Biocor porcine bioprosthesis. J Heart Valve Dis 2000;9:415-22.